GN
Gary Nachman Raymond James Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
10
Avg Return
Past Year
Past Year
4.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Strong Buy
Reiterated
| $89 |
18%
upside
| 2 | +35% |
0
%
| 30 Oct ‘25 4 months ago |
|
|
|
Outperform
Reiterated
| $19 |
10%
upside
| 1 | +11% |
0
%
| 30 Oct ‘25 4 months ago |
|
|
|
Outperform
Reiterated
| $50 |
307%
upside
| 2 | -22% |
0
%
| 20 Oct ‘25 4 months ago |
|
|
|
Outperform
Reiterated
| $250 |
10%
upside
| 3 | +7.3% |
0
%
| 17 Oct ‘25 4 months ago |
|
|
|
Market Perform
Assumed
| – | – | 1 | – |
–
| 3 Sep ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $20 |
713%
upside
| 1 | -22% |
0
%
| 13 Aug ‘25 6 months ago |
|